HCV Combination Therapies
作者： John J. Alam , Lindsay Mcnair , Robert S. Kauffman
DOI:
关键词:
摘要: The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a or without ribavirin. patients bridging fibrosis infected HCV using therapy.
lens.org 参考文章(29)
Nelson Dr, Davis Gl, Reyes Gr, FUTURE OPTIONS FOR THE MANAGEMENT OF HEPATITIS C Seminars in Liver Disease. ,vol. 19, pp. 103- 112 ,(1999)
A Takamizawa, C Mori, I Fuke, S Manabe, S Murakami, J Fujita, E Onishi, T Andoh, I Yoshida, H Okayama, Structure and organization of the hepatitis C virus genome isolated from human carriers Journal of Virology. ,vol. 65, pp. 1105- 1113 ,(1991) , 10.1128/JVI.65.3.1105-1113.1991
R Bartenschlager, L Ahlborn-Laake, J Mous, H Jacobsen, Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology. ,vol. 67, pp. 3835- 3844 ,(1993) , 10.1128/JVI.67.7.3835-3844.1993
C Lin, B M Prágai, A Grakoui, J Xu, C M Rice, Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. Journal of Virology. ,vol. 68, pp. 8147- 8157 ,(1994) , 10.1128/JVI.68.12.8147-8157.1994
L Tomei, C Failla, E Santolini, R De Francesco, N La Monica, NS3 is a serine protease required for processing of hepatitis C virus polyprotein. Journal of Virology. ,vol. 67, pp. 4017- 4026 ,(1993) , 10.1128/JVI.67.7.4017-4026.1993
N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, K. Shimotohno, Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 9524- 9528 ,(1990) , 10.1073/PNAS.87.24.9524
I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 6547- 6549 ,(1990) , 10.1073/PNAS.87.17.6547
Alfredo Alberti, Liliana Chemello, Luisa Benvegnù, None, Natural history of hepatitis C Journal of Hepatology. ,vol. 31, pp. 17- 24 ,(1999) , 10.1016/S0168-8278(99)80369-9
Michael A. Walker, Hepatitis C virus: an overview of current approaches and progress. Drug Discovery Today. ,vol. 4, pp. 518- 529 ,(1999) , 10.1016/S1359-6446(99)01414-2
Daniel N. Sauder, Immunomodulatory and pharmacologic properties of imiquimod Journal of the American Academy of Dermatology. ,vol. 43, pp. S6- S11 ,(2000) , 10.1067/MJD.2000.107808